Education
About Us
Working with TipRanks
Follow Us
Sanuwave Health (SNWV)
NASDAQ:SNWV
Total Valuation
Sanuwave Health has a market cap or net worth of $255.77M. The enterprise value is $211.76M.
Market Cap$255.77M
Enterprise Value$211.76M
Share Statistics
Sanuwave Health has 8,548,473 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,548,473
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sanuwave Health’s return on equity (ROE) is 2.47 and return on invested capital (ROIC) is -44.35%.
Return on Equity (ROE)2.47
Return on Assets (ROA)-1.04
Return on Invested Capital (ROIC)-44.35%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee709.43K
Profits Per Employee0.00
Employee Count46
Asset Turnover1.08
Inventory Turnover1.95
Valuation Ratios
The current PE Ratio of Sanuwave Health is -3.27. Sanuwave Health’s PEG ratio is 0.08.
PE Ratio-3.27
PS Ratio10.95
PB Ratio-8.07
Price to Fair Value-8.07
Price to FCF41.81
Price to Operating Cash Flow41.81
PEG Ratio0.08
Income Statement
In the last 12 months, Sanuwave Health had revenue of 32.63M and earned -31.37M in profits. Earnings per share was -7.03.
Revenue32.63M
Gross Profit24.55M
Operating Income5.42M
Pretax Income-31.34M
Net Income-31.37M
EBITDA-16.56M
Earnings Per Share (EPS)-7.03
Cash Flow
In the last 12 months, operating cash flow was 2.46M and capital expenditures -490.00K, giving a free cash flow of 1.97M billion.
Operating Cash Flow2.46M
Free Cash Flow1.97M
Free Cash Flow per Share0.23
Dividends & Yields
Sanuwave Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.18
52-Week Price Change289.60%
50-Day Moving Average30.31
200-Day Moving Average19.24
Relative Strength Index (RSI)43.12
Average Volume (3m)41.90K
Important Dates
Sanuwave Health upcoming earnings date is May 9, 2025, TBA Not Confirmed.
Last Earnings DateMar 21, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend Date―
Financial Position
Sanuwave Health as a current ratio of 0.43, with Debt / Equity ratio of -200.49%
Current Ratio0.43
Quick Ratio0.34
Debt to Market Cap<0.01
Net Debt to EBITDA0.61
Interest Coverage Ratio0.40
Taxes
In the past 12 months, Sanuwave Health has paid 27.00K in taxes.
Income Tax27.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Sanuwave Health EV to EBITDA ratio is -5.59, with an EV/FCF ratio of 37.72.
EV to Sales2.84
EV to EBITDA-5.59
EV to Free Cash Flow37.72
EV to Operating Cash Flow37.72
Balance Sheet
Sanuwave Health has $10.24M in cash and marketable securities with $5.52M in debt, giving a net cash position of $15.26M billion.
Cash & Marketable Securities$10.24M
Total Debt$5.52M
Net Cash$15.26M
Net Cash Per Share$1.78
Tangible Book Value Per Share-$5.31
Margins
Gross margin is 75.23%, with operating margin of 16.60%, and net profit margin of -96.13%.
Gross Margin75.23%
Operating Margin16.60%
Pretax Margin-96.05%
Net Profit Margin-96.13%
EBITDA Margin-50.75%
EBIT Margin-54.26%
Analyst Forecast
The average price target for Sanuwave Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast59.99%
EPS Growth Forecast57.11%